Research
Macro partitioning
Orlistat treatment improves obesity-related cardiovascular and metabolic risk factors, including lowering LDL cholesterol, total cholesterol, and fasting insulin levels, independent of the magnitude of weight loss.
Orlistat not only helps you lose weight but also independently improves your cholesterol levels (LDL and total) and insulin sensitivity. This benefit persists even when accounting for the amount of weight lost, suggesting a direct pharmacologic effect on lipid metabolism due to reduced fat absorption.
StrongSupportsVERY_HIGH confidence
Treatment with orlistat, 120 mg 3 times a day, was associated with improvements in fasting low-density lipoprotein cholesterol and insulin levels.
Why this rating
Large-scale RCT with rigorous statistical analysis (ANCOVA) controlling for weight loss.
Source
Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat
Michael Davidson et al. · JAMA · 1999
rct · n=1187Cited 944×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →